Triamcinolone Acetonide 0.015%

Verify with FDA CVM →

99 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
99
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Triamcinolone Acetonide 0.015%

Administration Routes

UnknownTopicalOral

Species Affected

Unknown 66
Dog 25
Human 7
Other Rodents 1

Most Affected Breeds

Unknown 74
Mixed (Dog) 4
Shepherd Dog - German 3
Poodle - Toy 2
Terrier - Boston 2
American Pit Bull Terrier 2
Pug 2
Hound - Basset 1
Spitz - German Pomeranian 1
Papillon - Spaniel - Continental Toy (with erect ears or with dropped ears (Phaléne)) 1

Most Reported Reactions

Uncoded sign 42
Containers, Leaking 32
Seal, Abnormal 17
Tubes, Leaking 10
Dispenser, Abnormal 6
Vomiting 4
Lethargy (see also Central nervous system depression in 'Neurological') 4
Product Defect, General 4
Cutaneous calcinosis 3
Diarrhoea 3
Reddening of the skin 3
Vials, Leaking 3

Outcome Breakdown

Recovered/Normal
19 (57.6%)
Outcome Unknown
11 (33.3%)
Ongoing
2 (6.1%)
Recovered with Sequela
1 (3.0%)

Data Summary

Metric Value
Total adverse event reports 99
Reports involving death 0
Case-fatality rate (reported events) 0.0%
Distinct species in reports 4
Distinct breeds in reports 17
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Triamcinolone Acetonide 0.015% Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 99 adverse event reports referencing Triamcinolone Acetonide 0.015%, including 0 reports in which the animal died — a 0.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Triamcinolone Acetonide 0.015%. Reported administration routes include Unknown, Topical, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Triamcinolone Acetonide 0.015% reports are Unknown (66 reports), Dog (25 reports), Human (7 reports), with Unknown accounting for the largest share. Within those species, Unknown (74), Mixed (Dog) (4), Shepherd Dog - German (3) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Triamcinolone Acetonide 0.015% are Uncoded sign (42), Containers, Leaking (32), Seal, Abnormal (17), Tubes, Leaking (10). Of the 33 reports with a coded outcome, Recovered/Normal is the leading category at 57.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Triamcinolone Acetonide 0.015%.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial